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Abstract: Stimulation of muscarinic receptors by carba-
chol and activation of protein kinase C elicits the translo-
cation of calmodulin (CaM) from membranes to cytosol
in the human neuroblastoma cell line SK-N-SH. Our previ-
ous studies have suggested a role for protein kinase C
in the regulation of CaM redistribution. To explore further
the role of protein kinase C in carbachol-inducedcalmod-
ulin translocation, we treated cells for 17 h with 12-0-
tetradecanoylphorbol 13-acetate (TPA) to down-regulate
protein kinase C isozymes or 72 h to differentiate the
cells. Treatment of SK-N-SH cells for 17 h with 70 nM
TPA nearly abolished the effect of carbachol on CaM
redistribution. After 72 h of TPA, however, the cells ap-
peared differentiated, and the ability of carbachol to in-
crease cytosolic CaM levels was restored. In untreated
control cells, the carbachol-mediated increase in cyto-
solic CaM content was mimicked by TPA and blocked
by pretreatment with the selective protein kinase C inhibi-
tor Ro 31 -8220 at 10 ~tM.In the 72-h TPA-treated cells,
however, the ability of TPA to increase cytosolic CaM
levels was significantly reduced, and the action of carba-
chol was no longer blocked by Ro 31-8220. The effect
of prolonged TPA treatment on select protein kinase C
isozymes was examined by immunoblotting. Treatment
of cells for either 17 or 72 h abolished the cn-isozyme in
the cytosol and reduced (17 h) or abolished (72 h) the
content in the membranes. In both 17- and 72-h TPA-
treated cells, the -isozymewas nearly abolished in the
cytosol and slightly reduced in the membranes. Some
protein kinase C activity may have been maintained dur-
ing TPA treatment because the basal level of phosphory-
lation of the protein kinase C substrate myristoylated ala-
nine-rich C kinase substrate was enhanced in cells
treated for either 17 or72 h with TPA. The potentialdisso-
ciation of carbachol and protein kinase C in eliciting in-
creases in cytosolic CaM content was a function of pro-
longed TPA treatment and not differentiation per se be-
cause carbachol-mediated increases in cytosolic CaM
levels were inhibited by Ro 31-8220 in retinoic acid-differ-
entiated SK-N-SH cells. This study demonstrates that
continuous TPA treatment, although initially down-regu-
lating the protein kinase C-mediated effect of carbachol
on CaM redistribution, uncouples carbachol and protein
kinase C at longer times. Key Words: Translocation—
Protein kinase C—Myristoylated alanine-rich C kinase
substrate—Carbachol—Differentiation—43-kDa growth-
associated protein.
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Calmodulin (CaM) was initially characterized as a
Ca2~-dependent activator of cyclic nucleotide phos-
phodiesterase and has since been shown to mediate
many effects of Ca2~in various cell reactions and
processes. CaM is an intracellular Ca2~binding protein
that is involved in regulation of cyclic nucleotide
metabolism, phosphorylation — dephosphorylation cas-
cades, cytoskeletal functions, ion channel activity, and
cell proliferation (Manalan and Klee, 1984). Knowl-
edge of the intracellular locations of CaM and changes
in response to stimuli, such as receptor activation, is
important to understanding functions and regulation of
CaM (Gnegy, 1993). The fact that binding of CaM to
various proteins can be altered by modifications such
as phosphorylation suggests the possibility that CaM
localization is regulated by intracellular signal-pro-
cessing mechanisms (Gnegy, 1993). In human neuro-
blastoma SK-N-SH cells, activation of muscarinic re-
ceptors mediates a translocation of CaM from mem-
brane into cytosol (Mangels and Gnegy, 1990). The
carbachol-mediated redistribution of CaM from mem-
brane into cytosol was attributed to the involvement
of both protein kinase C (PKC) activation and the
rise in intracellular Ca2~concentration (Mangels and
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Gnegy, 1990; McGinnis and Gnegy, 1996). The carba-
chol effect was predominantly mimicked by a phorbol
ester and blocked by a PKC inhibitor.
Continuous treatment of cells with a phorbol ester
such as 12-O-tetradecanoylphorbol 13-acetate (TPA)
initially down-regulates PKC activity but can also lead
to cellular differentiation (Blackshear, 1988; Pàhlman
et al., 1990). Although SK-N-SH cells have a neuronal
morphology, they can be induced to differentiate fur-
ther along a neuronal lineage (Pàhlman et al., 1990).
Differentiation of SK-N-SH cells and their clonal cell
line SH-SY5Y by TPA leads to neurite outgrowth and
increased expression of the neuronal 43-kDa growth-
associated protein, GAP-43 (Jalava et al., 1988; Pàhl-
man et al., 1990). Phorbol ester-induced differentia-
tion of SK-N-SH cells and the clonal cell line, SH-
SY5Y, decreases levels of components important in
muscarinic receptor-mediated translocation of CaM,
such as muscarinic receptor density, G protein-stimu-
lated phosphoinositide turnover, and PKC activity and
differentially regulates expression of PKC isoforms
(Cioffi and Fisher, 1990; Leli et al., 1993).
The objective of this study was to investigate the
effect of continuous TPA treatment leading to down-
regulation of PKC on muscarinic receptor-induced
changes in CaM localization. We found that treatment
with TPA for 17 h down-regulated specific PKC iso-
zymes and completely abolished carbachol-stimulated
increases in cytosolic CaM levels. Despite continuous
down-regulation of some specific PKC isozymes, the
carbachol effect was restored after treatment with TPA
for 72 h. Experiments with the specific PKC inhibitor
Ro 3 1-8220 suggested that the carbachol effect was
uncoupled from PKC after 72 h of TPA treatment.
This uncoupling was probably due to continuous TPA




Tissue culture supplies were from Corning Glass Works
(Corning, NY, U.S.A.). Cell culture reagents, Dulbecco’s
modified Eagle’s medium (DMEM), fetal bovine serum,
EGTA, bovine serum albumin, carbachol, Lubrol-PX, and
TPA were all purchased from Sigma Chemical Co. (St.
Louis, MO, U.S.A.). Monoclonal antibody to GAP-43 was
from Boehringer Mannheim. Affinity-purified isozyme-spe-
cific antisera against thea, ~, c, and ~ isozymes of PKC were
purchased from GibcoBRL (Grand Island, NY, U.S.A.). 32P-Inorganic phosphate (32P~)was purchased from Du Pont
NEN (Boston, MA, U.S.A.). Ro 3 1-8220 and genistein were
obtained from Calbiochem (San Diego, CA, U.S.A.).
Cell growth studies
The human neuroblastoma SK-N-SH cells were seeded,
grown, and harvested according to the technique of Mangels
and Gnegy (1990). Cells were treated with 70 nM TPA in
the culture medium for 17 or 72 h (Spinelli et al., 1982).
Differentiation of the cells has been reported after treatment
with 70 nM TPA for 72 h (Spinelli et al., 1982: Akcrman
et al., 1984). TPA was serially diluted in media from a I
mM stockdissolved in dimethyl sulfoxide such that the final
concentration of dimethyl sulfoxide in the growth media
was <0.01%. Cells were differentiated with retinoic acid by
addition of 1 p.M retinoic acid 48 h after seeding; growth
was continued for 6 days. Retinoic acid was serially diluted
in media from a 10 mM stock dissolved in ethanol such that
the concentration of ethanol in the growth media was 0. 1%.
Control media contained 0.1% ethanol. All cultures were fed
every 48 h. Cell viability was determined using trypan blue
exclusion. Differentiation was monitored by visually noting
increased neurite extension. Cell number was determined by
hemocytometer. Prominent neurite extension was found in
cells treated with either TPA for 72 h or retinoic acid. Al-
though the SK-N-SH cell line has been reported to exhibit
both neuroblast and epithelial phenotypes (Ross et al.,
1983), under our culture conditions. i.e., relatively pro-
longed culture at low initial subculture densities, only the
neuroblast phenotype is found (Sadee et a!.. 1987). All cells
were used within 8—10 days of subculture. Cells were seeded
at a density of ~—400,000cells per flask.
Cell treatment and subcellular fractionation
Cells were dislodged from the flasks in Puck’s buffer,
pelleted, and resuspended in incubation buffer (142 mM
NaCl, 30 mM sodium HEPES. 5.6 mM KCI. 3.6 mM
NaHCO~,2.2 mM CaCI
2. 1.0 mM MgCI2. and 5.6 mM o-
glucose, pH 7.4). Cells were treated with 100 pM carbachol
for variable intervals at 37°C.After incubation, cells were
homogenized in buffer containing 320 mM sucrose, 40 mM
Tris, 3 mM MgCI2. I pM leupeptin. I pM pepstatin, and 1
mMphenylmethylsulfonyl fluoride (pH 7.4), and IOO,
000-g
particulate (membrane) and supernatant (cytosol) fractions
were prepared as described (Mangels and Gnegy. 1990). In
inhibitor studies, cells were preincubated with either 10 pM
Ro 3 1-8220 for 5 mm or 100 pM genistein for 40 mm before
addition of 100 ftM carbachol.
Radioimmunoassay
CaM was quantified by using affinity-purified sheep anti-
CaM (Sweet et al., 1991 ) as described (Roberts-Lewis et
al., 1986). Cytosol samples were heated for 6 mm and partic-
ulate fractions for 12 mm before assay. Treatment and con-
trol groups were always assayed in the same experiment.
This was important because the basal levels of CaM would
vary from experiment to experiment.
Immunoblotting
Cell membrane and cytosol fractions were prepared, di-
luted in sample buffer, and separated by sodium dodecyl
sulfate—polyacrylamide gel electrophoresis (SDS-PAGE)
using the percentages of polyacrylamide indicated. Proteins
were electrophoretically transferred to nitrocellulose mem-
branes at 8 mA overnight. Blots were incubated in blocking
buffer [3% (wt/vol) dry milk, 0.2% Tween 20, 0.15 M
NaC1, and 20 mM Tris-HCI, pH 7.5] for I h. Antibodies
were diluted in blocking buffer as indicated in figure legends
and incubated with blots for 2 h. Alkaline phosphatase-con-
jugated anti-rabbit lgG (1:5,000) was incubated with blots
for 2 h and washed extensively. The antigen—antibody com-
plex was detected with 5-bromo-4-chloro-3-indolyl phos-
phate and nitroblue tetrazolium. All steps were performed
at room temperature.
J. Neurooheni., Vol. 6© No. 1, 1997
42 Z. SHARIAT-MADAR ET AL.
Myristoylated alanine-rich C kinase substrate
(MARCKS) phosphorylation
On the day of the experiment, medium was removed,
monolayers were washed twice with 2 ml of phosphate-free
(and serum-free) DMEM per well, and cells were incubated
for I h in phosphate-free DMEM at 37°C.Medium was
removed and replaced with 0.5 mCi of 32P~in I ml of phos-phate-free DMEM per well, and incubation was continued
as above for 2 h. Drugs (or vehicle) were added directly to
the medium for indicated times. Drug (TPA or carbachol)
preincubations were included as part of the 2-h labeling
period. The reaction was stopped by removing the radioac-
tive media by aspiration and washing the monolayers twice
with cold (4°C)Tris-buffered saline. The Tris-buffered sa-
line was removed, cells were extracted with 150—300 p1 of
2.5% perchloric acid (PCA), 150 mMNaCI, and 1% Triton
X-l00 (Deloulme et al., 1990), removed with a cell scraper,
and transferred into microfuge tubes on ice. Extracts were
sonicated for 15 mm in a water bath sonicator, centrifuged
for 10 mm at 15,000 g at 4°C,and then neutralized with 2 M
NaOH. Protein concentration of supernatants (PCA-soluble
fraction) was measured using the Pierce BCA protein assay
with bovine serum albumin as a standard. Data were quanti-
fied using either a Phosphorlmager (Molecular Dynamics,
Sunnyvale, CA, U.S.A.) or a Hoefer model GS365W scan-
ning densitometer (Hoefer Scientific Instruments, San Fran-
cisco, CA, U.S.A.). Peak areas were quantified by Gaussian
integration using theHoefer model GS365W electrophoresis
data system.
MARCKS immunoprecipitation
Immunoprecipitation of MARCKS from 32P-labeled cells
was performed as described (Lobaugh and Blackshear,
1990) using 5 pg of neutralized PCA-soluble extract per
condition. Samples were precleared by incubating while ro-
tating for 1 h at 4°Cwith a 1:100 dilution of normal rabbit
serum and 50 pl of a 20% slurry of protein A-Sepharose in
TEG buffer [10 mM TES (pH 7.6), 50 mM NaCI, 4 mM
EDTA, and 10% glycerol]. Samples were spun at 15,000 g
for 5 mm, and the pellet was discarded. Supernatants were
then incubated overnight with rotation at 4°Cwith a 1:100
dilution of MARCKS antiserum (generously provided by P.
Blackshear, Duke University), after which 50 p,1 of a 20%
slurry of protein A-Sepharose was added to each tube. Incu-
bation was continued for 2 h, and samples were centrifuged
as above. The supernatants were removed, and the immune
pellets were washed three times with 500 pl of TEG buffer.
The final pellets were subjected to electrophoresis on a 7%
sodium dodecyl sulfate-polyacrylamide gel, dried, and auto-
radiographed.
RESULTS
Effect of carbachol on CaM localization in
TPA-pretreated SK-N-SH cells
In control cells, carbachol elicited a robust increase
in cytosolic CaM and a decrease in particulate CaM
that was maximal at 15 mm (Fig. 1). After 17 h of
TPA, carbachol was unable to alter the localization of
CaM (Fig. 1). TPAwas similarly unable to redistribute
CaM in cells treated for 17 h with TPA (data not
shown). The ability of carbachol to redistribute CaM
was restored on continuing TPA treatment for 72 h
FIG. 1. Time course of carbachol-mediated CaM translocation
in untreated or 17- or 72-h TPA-treated SK-N-SH cells. Cells
were untreated (circles) or treated with 70 nM TPA for 17 (trian-
gles) or 72 h (diamonds). Cells were treated with 100 pM carba-
chol for variable intervals at 37°C,and CaM was quantified in
100,000-g supernatants (solid symbols) and pellets (open sym-
bols) as stated in Materials and Methods. Results for control
and 72-h TPA-treated cells are expressed as percentages of
values at zero-time and are mean ±SEM (bars) values of tripli-
cate determinations from three different experiments. Results for
17-h TPA-treated cells are the average of triplicate determina-
tions from two different experiments that did not differ by >5%.
Zero-time values for CaM (in ng per 106 cells) in cytosol and
membrane fractions are as follows: from nondifferentiated cells,
12 ±1.3 and 47 ±7; from 17-h TPA-treated cells, 16 and 53;
and from 72-h TPA-treated cells, 12 ±1 and 32 ±5, respectively.
(Fig. 1). In 72-h TPA-treated cells, carbachol elicited
an elevation of cytosolic CaM content that was not
significantly different from that in untreated cells.
Localization and immunoblotting of PKC
isozymes
We wished to examine whether select PKC iso-
zymes were down-regulated by the TPA treatment and
whether changes in isozyme content of PKC would
explain the difference in the carbachol response be-
tween 17- and 72-h TPA-treated cells. The contents of
the Ca2~-dependent PKC isozymes, a and /3, the Ca2~-
independent PKC isozyme, c, and the TPA- anddiacyl-
glycerol-independent PKC isozyme, ~, were deter-
mined by immunoblots in the membrane and cytosol
fractions of untreated cells and cells treated for 17 or
72 h with TPA. These are the predominant isozymes
in SK-N-SH cells (Baumgold and Dyer, 1994; Sproull
et al., 1995). In untreated control cells, a-PKC was
mainly localized in the cytosol, although a measurable
amount was detected in the particulate fraction (Fig.
2). Treatment of cells for either 17 or 72 h with TPA
abolished a-PKC in cytosol fractions and reduced (17
h) or abolished (72 h) a-PKC in membrane fractions.
In untreated cells, /3-PKC waspredominantly localized
in the cytosol, although a low but detectable amount
was detected in the particulate fraction. In cells treated
for either 17 or 72 h with TPA, the /3-PKC in the
cytosol remained virtually unchanged from that in non-
differentiated controls, and some /3-PKC was faintly
detected in the membranes. In nondifferentiated cells,
e-PKC was more evenly distributed between cytosol
and membranes. In both 17- and 72-h TPA-treated
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FIG. 2. Immunoblot analysis of subcellular distribution of a-,
r-, and 1-PKC isozymes in untreated SK-N-SH cells (Con)
and cells treated for 17 or 72 h with TPA. Immunoblot analysis
of the PKC isozymes was performed in the 100,000-g cytosol
(C) and membrane (M) fractions prepared as described in Mate-
rials and Methods. Cytosol (25 pg) and membrane (40 pg) frac-
tions from SK-N-SH cells were separated by SDS-PAGE using
8.75% polyacrylamide. The molecular weight (MW) markers are
given in the far left lane.
cells, c-PKC was nearly abolished in the cytosol and
reduced in the membranes. In contrast, ç-PKC, which
was present at low levels in the cells, was not altered
by 72-h TPA treatment.
Effect of TPA treatment on activity of PKC as
assessed by phosphorylation of MARCKS
To assess the effect of the TPA treatments on PKC
activity, the phosphorylation of a PKC substrate, the
CaM-binding protein MARCKS, was determined. The
MARCKS protein was visible as a phosphoprotein
band at 86 kDa in a PCA extract prepared from 32P~-
preincubated SK-N-SH cells. Identity of MARCKS as
the 86-kDa band was confirmed using immunoprecipi-
tation with MARCKS-specific antisera generously do-
nated by Dr. Perry Blackshear (Duke University) (Fig.
3C). As shown in Fig. 3A, in nontreated cells, phos-
phorylation of MARCKS was increased by 100 ,uM
carbachol and was robustly stimulated by TPA. In cells
treated for either 17 or 72 h with TPA (Fig. 3B and
C), phosphorylation of MARCKS was significantly
enhanced under basal conditions, and the protein could
not be further phosphorylated by either carbachol or
TPA.
Effect of PKC inhibition on carbachol-mediated
increases in cytosolic CaM content after TPA
treatment
To explore further the role of PKC in carbachol-
mediated CaM redistribution in 72-h TPA-treated SK-
N-SH cells, the effect of the specific PKC inhibitor Ro
31-8220 was determined. As shown in Table 1, both
100 ,uM carbachol and 25 n M TPA increased cytosolic
CaM content in untreated cells. Preincubation of the
cells with 10 RMRo 3 1-8220 significantly blocked the
effect of both carbachol and TPA in increasing cyto-
solic CaM. In cells treated for 72 h with TPA, the
ability of carbachol to elicit increases in cytosolic CaM
was similar to that of the control, but the effect of 25
nMTPA was significantly reduced. The weak stimulat-
ing effect of TPA was further reduced by preincubation
with 10 ~M Ro 31-8220. The effect of carbachol, how-
ever, was not blocked by preincubation with Ro 31-
8220, suggesting that the carbachol action was no
longer mediated by PKC. On the other hand, carba-
chol-mediated increases in cytosolic CaM content in
both untreated and 72-h TPA-treated SK-N-SH cells
were blocked by treatment with 100 ftM genistein.
Effect of retinoic acid differentiation on
carbachol-mediated increases in cytosolic CaM
content
Treatment of SK-N-SH cells and its clonal cell line,
SH-SY5Y, for 72 h with 70 nM TPA differentiates the
FIG. 3. Phosphorylation of MARCKS in (A) untreated control
(Ctrl) or (B) 17- and 72-h TPA-treated SK-N-SH cells. Cells were
treated with TPA as described in Materials and Methods. For the
experiment, cells were prelabeled with 32P, for 2 h as described in
Materials and Methods including incubation with 100 pM carba-
chol for 30s or 100 nM TPA for 15 mm. The reaction was stopped
with 2.5% PCA and neutralized as described in Materials and
Methods, and 5 pg of PCA-soluble protein per lane was applied
to SDS-PAGE using 7.5% polyacrylamide. C: MARCKS was im-
munoprecipitated from neutralized 32P-labeled PCA-soluble
fractions from either control SK-N-SH cells or cells treated for
17 or 72 h with 70 nM TPA. MARCKS was immunoprecipitated
from 5 pg of precleared PCA-soluble protein as described in
Materials and Methods. lmmunoprecipitates were electropho-
resed on 7% polyacrylamide gels, which were then dried and
autoradiographed.
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TABLE 1. Inhibition of carbachol- and TPA-mediated
increases in cytosolic CaM content
Cell pretreatment
% Stimulation wi th activator
100 pM Carbachol 25 nM TPA
Untreated cells
None 274 ±26° 315 ±34°
10pM Ro 31-8220 91 ±33 140 ±27
100 pM genistein 99 ±18 ND
72-h TPA-treated cells
None 250 ±21° 151 ±10°
10 pM Ro 31-8220 200 ±19° III ±13
100 pM genistein 90 ±I ND
Retinoic acid-treated cells
None 252 ±52” 287 ±52”
10 pM Ro 31-8220 115 ±23 139 ±49
Cells were untreated or treated with 70 nM TPA for 72 h or
retinoic acid for 6 days as described in Materials and Methods. Cells
were incubated with 10 pM Ro 31-8220 for 5 mm or 100 pM
genistein for 40 mm before addition of buffer, 100 pM carbachol,
or 25 nM TPA for an additional 15 mm. Results are expressed as
percent stimulation of cytosolic CaM content over buffer controls
and are mean ±SEM values (n = 4). Neither Ro 31-8220 nor
genistein significantly affected basal cytosolic CaM content. ND,
not determined.
“p < 0.005, significantly different from 100%.
cells (Spinelli et al., 1982; Akerman et al., 1984). We
wished to determine whether the alteration in coupling
of carbachol-mediated increases in cytosolic CaM to
PKC was a general function of differentiation or a
result of continuous TPA treatment. Therefore, we dif-
ferentiated SK-N-SH cells withretinoic acid and exam-
ined the effect of Ro 31-8220 on carbachol-mediated
increases in cytosolic CaM. In both TPA- and retinoic
acid-differentiated cells, we found responses denoting
differentiation: neurite extension (data not shown) and
an increase in the growth-associated protein, GAP-43
(Fig. 4) (Kuramoto et al., 1981; Pàhlman eta!., 1990).
In retinoic acid-differentiated cells, increases in cyto-
solic CaM elicited by both carbachol and TPA were
blocked by preincubation with 10 ,aM Ro 31-8220 (Ta-
ble 1). Therefore, carbachol-mediated CaM redistribu-
tion in retinoic acid-differentiated cells appeared cou-
pled to PKC as in untreated cells.
DISCUSSION
In this study we examined the effect of long-term
TPA treatments on carbachol-mediated CaM redistri-
bution in human neuroblastoma SK-N-SH cells. Short-
term incubation (15 mm) withTPA mimicks carbachol
in causing an increase in CaM in the cell cytosol
(Mangels and Gnegy, 1990; present study). In addi-
tion, the carbachol-mediated redistribution of CaM is
inhibited by the PKC inhibitor H-7 (Mangels and
Gnegy, 1990) and the more specific inhibitor Ro 31-
8220 (present study). Increasing the timeof incubation
with TPA to 17 h resulted in a total blockade of the
carbachol effect, probably through down-regulation of
protein kinase isozymes. After 72 h of TPA treatment,
the efficacy of carbachol in increasing cytosolic CaM
was the same as in untreated cells but was no longer
blocked by the PKC inhibitor Ro 3 1-8220. At 72 h of
TPA treatment, the PKC isozymes were still down-
regulated. This suggests that the mechanism by which
carbachol elicits increases in cytosolic CaM in 72-h
TPA-treated cells has become uncoupled from PKC.
Decreases in PKC content and activity have been
reported in cells treated for prolonged times with TPA
(Cioffi and Fisher, 1990; Trejo and Brown, 1991; Leli
et al., 1993). We found reductions in content of both
a and isozymes of PKC in cytosol and membranes
from cells treated for 17 and 72 h. There was no de-
crease, and perhaps even a slight enhancement, in con-
tent of the /3-PKC isozyme after TPA treatment. The
same results were found by Leli et al. (1993) in SH-
SY5Y cells differentiated with 10 nM TPA. Parrow et
al. (1995), however, found that the a- and -PKC
forms were enriched in growth cones of TPA-differen-
tiated SH-SY5Y cells. On the other hand, some PKC
activity is maintained throughout the TPA treatment.
We found an increased level of phosphorylation of
MARCKS in 17- and 72-h TPA-treated cells. Because
it occurred in cells treated for only 17 h with TPA,
this increase began before cells were significantly dif-
ferentiated. Elevated MARCKS phosphorylation has
been reported in TPA-differentiated SH-SY5Y cells
(Parrow et al., 1992). Blackshear (1988) found that
a TPA treatment that down-regulated 95% of the PKC
activity in human astrocytoma cells resulted in an
FIG. 4. Western blotanalysisof GAP-43. GAP-43/neuromodulin
was quantified by immunoblot in homogenate fractions from (A)
untreated control (Con) and 72-h TPA-treated SK-N-SH cells
(10 pg each) and (B) untreated and retinoic acid (RA)-treated
SK-N-SH cells using a monoclonal antibody to GAP-43 as de-
scribed in Materials and Methods. In A, the protein was obtained
from the PCA-soluble fraction as described in Materials and
Methods and separated by SDS-PAGE using 7.5% polyacryl-
amide. In B, the following concentrations were used: untreated
Con SK-N-SH cells, 40 pg; RA-differentiated SK-N-SH cells, 40
pg; and bovine brain homogenate (BB), 40 pg. Proteins (non—
PCA-precipitated) were separated by SOS-PAGE using 13%
polyacrylamide. Molecular sizes are shown. The difference in
apparent molecular size of GAP-43 between A and B is due to
the difference in percentage of polyacrylamide in the SDS-PAGE
(Benowitz et al., 1987).
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enhanced phosphorylation of MARCKS at the PKC-
phosphorylated sites. Although MARCKS is a sub-
strate for other protein kinases, such as a proline-di-
rected kinase (Taniguchi et al., 1994) and a PKC-
related kinase (Palmer et al., 1996), there was no
further phosphorylation in the presence of TPA, sug-
gesting that the PKC substrate sites were already occu-
pied. The PKC phosphorylation site in pp6O°” is also
phosphorylated early in TPA differentiation in SH-
SY5Y cells (Bjelfman et al., 1990; Pàhlman et al.,
1990).
Despite the apparent maintenance of a constitutive
PKC activity, the decrease in carbachol- and TPA-
mediated redistribution of CaM in 17-h TPA-treated
cells is likely to be due to the observed decrease in
content of a- and c-PKC. The decrease in TPA-medi-
ated CaM redistribution is maintained in 72-h TPA-
treated cells, reflecting the continued down-regulation
of a- and e-PKC. The observed effectiveness of carba-
chol in 72-h TPA-treated cells may not be due to PKC
activation as the PKC inhibitor Ro 3 1-8220 did not
inhibit the carbachol effect. Carbachol stimulates sev-
eral signal transduction activities in SK-N-SH and SH-
SY5Y cells. Both carbachol and TPA increase tyrosine
kinase activity (Baumgold and Fishman, 1988), and
carbachol can increase cyclic AMP formation (Of-
fermanns et al., 1993). We have shown that cyclic
AMP can alter CaM localization in SK-N-SH cells,
although it is not as active as carbachol (Mangels and
Gnegy, 1992). The ability of genistein to inhibit the
carbachol effect in untreated cells further suggests that
several signal transduction events can be important in
carbachol-mediated CaM redistribution. Genistein, at
concentrations that inhibit tyrosine kinase, has been
shown to inhibit Ca2~fluxes in several cell types (Lee
et al., 1993; Sargeant et at., 1993a,b). Studies suggest
that genistein selectively blocks agonist-induced entry
of extracellular Ca2~into cells (Lee et al., 1993;
Sargeant et al., 1993a,b). Although Ca2~is important
for carbachol-mediated CaM redistribution, our studies
suggest that external Ca2~is not able to mediate CaM
redistribution and that Ca2~released from internal
stores is required (McGinnis and Gnegy, 1996). lnter-
actions between tyrosine kinases and PKC activities
have been reported; for instance, activation of PKC
leads to activation of tyrosine phosphorylation in hip-
pocampal slices (Stratton et al., 1989; Siciliano et al.,
994). Therefore, it is possible that a signal transduc-
tion event in addition to PKC activation is involved in
CaM redistribution and that this event, perhaps tyro-
sine kinase activation, is operative in untreated and 72-
h TPA-treated cells. It is also likely that this signal
transduction event is not dependent on intracellular
Ca2~release because a decrease in carbachol-mediated
release of intracellular Ca2~in TPA-differentiated SH-
SY5Y cells has been reported (Cioffi and Fisher,
1990). We have replicated this finding (K. M.
McGinnis, personal communication). This uncoupling
from PKC is a result of TPA treatment and not a func-
tion of differentiation per se, as Ro 31-8220 was active
in blocking the carbachol-mediated increases in cyto-
solic CaM level in retinoic acid-differentiated cells.
Potential substrates for PKC phosphorylation re-
sulting in CaM redistribution in cells are MARCKS
and GAP-43 (neuromodulin, B-SO, P57, Fl) (Coggins
and Zwiers, 1991; Aderem, 1995). Both proteins are
CaM-binding proteins that have been proposed to act
as CaM depot proteins. Phosphorylation of the proteins
by PKC results in a dissociation of CaM (Liu and
Storm, 1990; Coggins and Zwiers, 1991; Aderem,
1995). MARCKS is an actin-binding protein that binds
and cross-links actin filaments. The cross-linking is
disrupted by both phosphorylation and Ca2~/CaM.
The high level of basal phosphorylation and the lack
of further response to TPA or carbachol suggest that
MARCKS plays no role in carbachol-stimulated CaM
redistribution in 72-h TPA-treated cells. The constitu-
tive phosphorylation of MARCKS could suggest al-
tered actin cross-linking in TPA-treated cells. GAP-43
is a neuron-specific protein bound to the cytoskeleton
and membrane skeleton (Liu and Storm, 1990; Cog-
gins and Zwiers, 1991). Despite elevation of GAP-43
content in TPA-differentiated cells, there is no en-
hancement in carbachol-mediated CaM redistribution
as compared with untreated cells. In the TPA-differen-
tiated cells, however, carbachol appears uncoupled
from PKC. It is likely, as suggested by the experiments
with genistein, that other substrates and enzymes are
involved in CaM redistribution in 72-h TPA-treated
cells.
In conclusion, PKC activation appears to be an im-
portant intermediate for muscarinic receptor-mediated
CaM redistribution in untreated SK-N-SH cells. Treat-
ment of cells for 17 h, a time at which PKC is down-
regulated, also down-regulates the muscarinic recep-
tor-mediated CaM redistribution. In cells treated with
TPA for 72 h, which are differentiated, the carbachol
effect is restored but appears to be uncoupled from
TPA-stimulated PKC activity. It is possible that an-
other signal transduction event becomes more promi-
nent in mediating the carbachol action in cells treated
for 72 h with TPA.
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